OBJECTIVE: to compare blood loss in women actively and expectantly managed in the third stage of labour. DESIGN: randomised controlled trial (RCT). SETTING: two delivery units at a Swedish university hospital. POPULATION: healthy women with normal pregnancies, at gestational age 34-43 weeks, with singleton cephalic presentation and expected vaginal delivery. METHODS: the women were randomly allocated to either active (n = 903) or expectant (n = 899) management of the third stage of labour. MAIN OUTCOME MEASURES: the primary outcome was blood loss > 1000 ml, and secondary outcomes were mean blood loss, duration of third stage, retained placenta, haemoglobin level and blood transfusion. RESULTS:blood loss > 1000 ml occurred in 10% of the actively managed group and 16.8% of the expectantly managed group (P < 0.001). Mean blood loss was 535 ml in the actively managed group and 680 ml in the expectantly managed group (P < 0.001). A prolonged duration of the third stage was associated with increased blood loss. Increased placenta weight was associated with increased blood loss. The haemoglobin level was 118 g/dl in actively managed women and 115/dl in expectantly managed women (P < 0.001) the day after childbirth. The occurrence of retained placenta and the number of blood transfusions did not differ between the groups. CONCLUSIONS: active management of the third stage of labour was associated with less blood loss compared with expectant management. It is reasonable to advocate this regime, especially in primiparous women.
RCT Entities:
OBJECTIVE: to compare blood loss in women actively and expectantly managed in the third stage of labour. DESIGN: randomised controlled trial (RCT). SETTING: two delivery units at a Swedish university hospital. POPULATION: healthy women with normal pregnancies, at gestational age 34-43 weeks, with singleton cephalic presentation and expected vaginal delivery. METHODS: the women were randomly allocated to either active (n = 903) or expectant (n = 899) management of the third stage of labour. MAIN OUTCOME MEASURES: the primary outcome was blood loss > 1000 ml, and secondary outcomes were mean blood loss, duration of third stage, retained placenta, haemoglobin level and blood transfusion. RESULTS:blood loss > 1000 ml occurred in 10% of the actively managed group and 16.8% of the expectantly managed group (P < 0.001). Mean blood loss was 535 ml in the actively managed group and 680 ml in the expectantly managed group (P < 0.001). A prolonged duration of the third stage was associated with increased blood loss. Increased placenta weight was associated with increased blood loss. The haemoglobin level was 118 g/dl in actively managed women and 115/dl in expectantly managed women (P < 0.001) the day after childbirth. The occurrence of retained placenta and the number of blood transfusions did not differ between the groups. CONCLUSIONS: active management of the third stage of labour was associated with less blood loss compared with expectant management. It is reasonable to advocate this regime, especially in primiparous women.
Authors: Nicole Campion; Cassandra L Thiel; Justin DeBlois; Noe C Woods; Amy E Landis; Melissa M Bilec Journal: Sci Total Environ Date: 2012-04-05 Impact factor: 7.963
Authors: Cecily M Begley; Gillian Ml Gyte; Declan Devane; William McGuire; Andrew Weeks; Linda M Biesty Journal: Cochrane Database Syst Rev Date: 2019-02-13
Authors: Rita de Cássia Teixeira Rangel; Maria de Lourdes de Souza; Cheila Maria Lins Bentes; Anna Carolina Raduenz Huf de Souza; Maria Neto da Cruz Leitão; Fiona Ann Lynn Journal: Rev Lat Am Enfermagem Date: 2019-08-19
Authors: Ioannis D Gallos; Helen M Williams; Malcolm J Price; Abi Merriel; Harold Gee; David Lissauer; Vidhya Moorthy; Aurelio Tobias; Jonathan J Deeks; Mariana Widmer; Özge Tunçalp; Ahmet Metin Gülmezoglu; G Justus Hofmeyr; Arri Coomarasamy Journal: Cochrane Database Syst Rev Date: 2018-04-25
Authors: Marrit Smit; Susanne I C Sindram; Mallory Woiski; Johanna M Middeldorp; Jos van Roosmalen Journal: BMC Pregnancy Childbirth Date: 2013-10-20 Impact factor: 3.007